The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in ...
Mayo Clinic received a federal grant to investigate ibudilast, an experimental drug for ALS (Lou Gehrig's disease). The drug, approved in Japan for asthma, is being tested in the U.S. under the ...
An average person starting GLP-1 medications for weight loss have been cited as averaging approximately 2.3% of their body weight in this same period. The same participants on The Mayo Clinic Diet ...
Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and ...
The grant totals $22 million. Mayo Clinic will receive $12 million and manage the distribution of the remainder to its collaborators. The U.S. Food and Drug Administration has granted Expanded ...